13F-HR filed by Lion Point Capital, LP
Lion Point Capital, LP filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 27 holding rows worth $17,601,836.
- Accession
- 0001013594-25-001425
- Filer
- CIK 1643354
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 27 entries on the cover page, a total value of $17,601,836 stated on the cover page (in dollars after the unit check, H1), rows summing to $17,601,836 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 39,000 | $1,478,880 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 658,553 | $1,317,106 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 123,000 | $1,151,280 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 398,558 | $948,568 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 59,700 | $911,619 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 23,400 | $908,622 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 6,250 | $900,063 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 162,750 | $896,753 | dollars as filed | |
| BENITEC BIOPHARMA INC | 08205P209 | COMMON STOCK | 62,000 | $869,860 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 55,000 | $846,175 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 21,400 | $754,992 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 10,600 | $700,448 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 13,300 | $690,802 | dollars as filed | |
| GERON CORP | 374163103 | COM | 500,000 | $685,000 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 35,300 | $665,405 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 57,750 | $557,288 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R201 | CMN | 27,138 | $522,135 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 67,500 | $483,975 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 46,000 | $407,100 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 22,700 | $340,727 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 58,000 | $332,340 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 5,700 | $302,100 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 42,000 | $296,100 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 86,000 | $280,360 | dollars as filed | |
| MERSANA THERAPEUTICS INC | 59045L205 | COM | 25,760 | $199,898 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 83,500 | $145,290 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 1,000 | $8,950 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-25-001425 | this filing | 2025-11-14 | acceptance time not in the bulk data set |